Skip to main content
PMC home page
Transactions of the American Clinical and Climatological Association logoLink to Transactions of the American Clinical and Climatological Association
. 2001;112:27–33.

TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy.

S Goldfarb 1, F N Ziyadeh 1
PMCID: PMC2194397  PMID: 11413780

Abstract

In summary, metabolic, hemodynamic, and genetic factors are all important in the development and progression of diabetic nephropathy (33). Recent studies using cell culture techniques and experimental animal models have provided important insight into the role of hyperglycemia in this disease. The nature of the factors directly arising as a consequence of hyperglycemia and the steps involved in diabetic complications are not completely understood. The characteristic lesions of diabetic nephropathy may be intimately related to the effects of high ambient glucose on intracellular signaling events, various growth factors/cytokines, and nonenzymatic glycation of proteins (36). The growth factor TGF-beta has emerged as a key participant in the cascade of events which leads to kidney sclerosis. Increased TGF-beta expression in the kidney in diabetes mellitus mediates the renal actions of high ambient glucose to promote cellular hypertrophy and stimulate extracellular matrix biosynthesis. Neutralizing the actions of TGF-beta with highly specific monoclonal antibodies or with application of antisense technology can effectively prevent the induction of the kidney lesions of diabetes in mice independent of any changes in blood glucose levels. Such maneuvers are crucial for establishing proof-of-concept and Koch's postulates (17), but they are still far removed from clinical applicability. Nevertheless, it is hoped that further studies to elucidate the efficacy of novel interventions to intercept the activity of the renal TGF-beta system will prove useful for effectively halting the progression of diabetic nephropathy.

Full text

PDF
27

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayo S. H., Radnik R. A., Garoni J. A., Glass W. F., 2nd, Kreisberg J. I. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol. 1990 Jun;136(6):1339–1348. [PMC free article] [PubMed] [Google Scholar]
  2. Clouthier D. E., Comerford S. A., Hammer R. E. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. J Clin Invest. 1997 Dec 1;100(11):2697–2713. doi: 10.1172/JCI119815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen M. P., Sharma K., Jin Y., Hud E., Wu V. Y., Tomaszewski J., Ziyadeh F. N. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy. J Clin Invest. 1995 May;95(5):2338–2345. doi: 10.1172/JCI117926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Du X. L., Edelstein D., Rossetti L., Fantus I. G., Goldberg H., Ziyadeh F., Wu J., Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12222–12226. doi: 10.1073/pnas.97.22.12222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Han D. C., Hoffman B. B., Hong S. W., Guo J., Ziyadeh F. N. Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol. 2000 Apr;278(4):F628–F634. doi: 10.1152/ajprenal.2000.278.4.F628. [DOI] [PubMed] [Google Scholar]
  6. Han D. C., Isono M., Hoffman B. B., Ziyadeh F. N. High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: mediation by autocrine activation of TGF-beta. J Am Soc Nephrol. 1999 Sep;10(9):1891–1899. doi: 10.1681/ASN.V1091891. [DOI] [PubMed] [Google Scholar]
  7. Hoffman B. B., Sharma K., Zhu Y., Ziyadeh F. N. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int. 1998 Oct;54(4):1107–1116. doi: 10.1046/j.1523-1755.1998.00119.x. [DOI] [PubMed] [Google Scholar]
  8. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T., Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest. 1993 Dec;92(6):2597–2601. doi: 10.1172/JCI116874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iwano M., Kubo A., Nishino T., Sato H., Nishioka H., Akai Y., Kurioka H., Fujii Y., Kanauchi M., Shiiki H. Quantification of glomerular TGF-beta 1 mRNA in patients with diabetes mellitus. Kidney Int. 1996 Apr;49(4):1120–1126. doi: 10.1038/ki.1996.162. [DOI] [PubMed] [Google Scholar]
  10. Johnson R. J., Lovett D. In vivo gene transfer, Koch's postulates, and renal disease. J Clin Invest. 1993 Dec;92(6):2568–2568. doi: 10.1172/JCI116870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kolm-Litty V., Sauer U., Nerlich A., Lehmann R., Schleicher E. D. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest. 1998 Jan 1;101(1):160–169. doi: 10.1172/JCI119875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kolm V., Sauer U., Olgemöller B., Schleicher E. D. High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol. 1996 May;270(5 Pt 2):F812–F821. doi: 10.1152/ajprenal.1996.270.5.F812. [DOI] [PubMed] [Google Scholar]
  13. Kopp J. B., Factor V. M., Mozes M., Nagy P., Sanderson N., Böttinger E. P., Klotman P. E., Thorgeirsson S. S. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest. 1996 Jun;74(6):991–1003. [PubMed] [Google Scholar]
  14. Koya D., Jirousek M. R., Lin Y. W., Ishii H., Kuboki K., King G. L. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997 Jul 1;100(1):115–126. doi: 10.1172/JCI119503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mogyorósi A., Ziyadeh F. N. Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hypertens. 1996 May;5(3):243–253. doi: 10.1097/00041552-199605000-00010. [DOI] [PubMed] [Google Scholar]
  16. Nakamura T., Ebihara I., Fukui M., Tomino Y., Koide H. Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes. 1995 Aug;44(8):895–899. doi: 10.2337/diab.44.8.895. [DOI] [PubMed] [Google Scholar]
  17. Nakamura T., Fukui M., Ebihara I., Osada S., Nagaoka I., Tomino Y., Koide H. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 1993 Mar;42(3):450–456. doi: 10.2337/diab.42.3.450. [DOI] [PubMed] [Google Scholar]
  18. Ohno M., Cooke J. P., Dzau V. J., Gibbons G. H. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest. 1995 Mar;95(3):1363–1369. doi: 10.1172/JCI117787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Riser B. L., Cortes P., Heilig C., Grondin J., Ladson-Wofford S., Patterson D., Narins R. G. Cyclic stretching force selectively up-regulates transforming growth factor-beta isoforms in cultured rat mesangial cells. Am J Pathol. 1996 Jun;148(6):1915–1923. [PMC free article] [PubMed] [Google Scholar]
  20. Rocco M. V., Chen Y., Goldfarb S., Ziyadeh F. N. Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int. 1992 Jan;41(1):107–114. doi: 10.1038/ki.1992.14. [DOI] [PubMed] [Google Scholar]
  21. Sharma K., Jin Y., Guo J., Ziyadeh F. N. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes. 1996 Apr;45(4):522–530. doi: 10.2337/diab.45.4.522. [DOI] [PubMed] [Google Scholar]
  22. Sharma K., Ziyadeh F. N., Alzahabi B., McGowan T. A., Kapoor S., Kurnik B. R., Kurnik P. B., Weisberg L. S. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes. 1997 May;46(5):854–859. doi: 10.2337/diab.46.5.854. [DOI] [PubMed] [Google Scholar]
  23. Sharma K., Ziyadeh F. N. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol. 1997 Mar;17(2):80–92. [PubMed] [Google Scholar]
  24. Sharma K., Ziyadeh F. N. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes. 1995 Oct;44(10):1139–1146. doi: 10.2337/diab.44.10.1139. [DOI] [PubMed] [Google Scholar]
  25. Sharma K., Ziyadeh F. N. Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol. 1994 Dec;267(6 Pt 2):F1094–F1001. doi: 10.1152/ajprenal.1994.267.6.F1094. [DOI] [PubMed] [Google Scholar]
  26. Studer R. K., Negrete H., Craven P. A., DeRubertis F. R. Protein kinase C signals thromboxane induced increases in fibronectin synthesis and TGF-beta bioactivity in mesangial cells. Kidney Int. 1995 Aug;48(2):422–430. doi: 10.1038/ki.1995.310. [DOI] [PubMed] [Google Scholar]
  27. Wolf G., Sharma K., Chen Y., Ericksen M., Ziyadeh F. N. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int. 1992 Sep;42(3):647–656. doi: 10.1038/ki.1992.330. [DOI] [PubMed] [Google Scholar]
  28. Wolf G., Ziyadeh F. N. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int. 1999 Aug;56(2):393–405. doi: 10.1046/j.1523-1755.1999.00590.x. [DOI] [PubMed] [Google Scholar]
  29. Wolf G., Ziyadeh F. N. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis. 1997 Jan;29(1):153–163. doi: 10.1016/s0272-6386(97)90023-8. [DOI] [PubMed] [Google Scholar]
  30. Yamamoto T., Noble N. A., Cohen A. H., Nast C. C., Hishida A., Gold L. I., Border W. A. Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int. 1996 Feb;49(2):461–469. doi: 10.1038/ki.1996.65. [DOI] [PubMed] [Google Scholar]
  31. Yang C. W., Vlassara H., Peten E. P., He C. J., Striker G. E., Striker L. J. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9436–9440. doi: 10.1073/pnas.91.20.9436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ziyadeh F. N., Han D. C., Cohen J. A., Guo J., Cohen M. P. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int. 1998 Mar;53(3):631–638. doi: 10.1046/j.1523-1755.1998.00815.x. [DOI] [PubMed] [Google Scholar]
  33. Ziyadeh F. N., Hoffman B. B., Han D. C., Iglesias-De La Cruz M. C., Hong S. W., Isono M., Chen S., McGowan T. A., Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):8015–8020. doi: 10.1073/pnas.120055097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ziyadeh F. N. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Miner Electrolyte Metab. 1995;21(4-5):292–302. [PubMed] [Google Scholar]
  35. Ziyadeh F. N., Mogyorósi A., Kalluri R. Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease. Exp Nephrol. 1997 Jan-Feb;5(1):2–9. [PubMed] [Google Scholar]
  36. Ziyadeh F. N., Sharma K., Ericksen M., Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest. 1994 Feb;93(2):536–542. doi: 10.1172/JCI117004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Ziyadeh F. N., Snipes E. R., Watanabe M., Alvarez R. J., Goldfarb S., Haverty T. P. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol. 1990 Oct;259(4 Pt 2):F704–F714. doi: 10.1152/ajprenal.1990.259.4.F704. [DOI] [PubMed] [Google Scholar]
  38. Ziyadeh F. N. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis. 1993 Nov;22(5):736–744. doi: 10.1016/s0272-6386(12)80440-9. [DOI] [PubMed] [Google Scholar]
  39. van Det N. F., Verhagen N. A., Tamsma J. T., Berden J. H., Bruijn J. A., Daha M. R., van der Woude F. J. Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes. 1997 May;46(5):834–840. doi: 10.2337/diab.46.5.834. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Clinical and Climatological Association are provided here courtesy of American Clinical and Climatological Association

RESOURCES